Stock·NYSE·Industrials
The Boeing Company (BA)
- Market cap
- $150.34B
- P/E
- 68.13
- Dividend yield
- None (suspended)
- Street target
- $270.00median of 28 analysts
- 52-week range
- $176.77 $254.35
The short version
Where BA stands today, in four lines, and what CleaRank Financial AI makes of it.
BA at a glance
The Boeing Company (BA): Hold, 45/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($205.37 and $219.50).
- Earnings BA beat estimates in 3 of its last 3 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $11.6M and bought $1.4M over the last 18 months.
- Valuation P/E of 68.1 against 34.0 for the Industrials sector: a premium to peers (+100%).
Figures as of October 17, 2026.
CleaRank Financial AI
BA, The Boeing Company, receives a CleaRank rating of Hold and a model score of 45/100.
The analysts' outlook lifts the score the most. 24 of 28 analysts rate it a buy, and the median target is 41.9% above the price. The trend holds the score back the most: the price is 13.34% below its 200-day average and 7.38% below its 50-day average, and the 50-day average is 6.44% below the 200-day. The 50-day stands at $205.37 and the 200-day at $219.50, and over the past year the price fell 10.23%.
Only on CleaRank
Figures we compute ourselves from BA's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $190.21 is 7.4% below the 50-day simple moving average of $205.37.Price above its 200-day average ›
The price is 13.3% below the 200-day simple moving average of $219.50.50-day average above the 200-day ›
The 50-day average ($205.37) is 6.4% below the 200-day average ($219.50), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 17% of its 52-week range, between $176.77 and $254.35.
BA share price
Pick a period: each tab shows how far BA has moved over it, to the last close.
Today's trading
Where BA sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 68.13 is 100.4% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 1.59 is 60.3% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $2.1B on revenue of $94.0B, a net margin of 2.2%.Beat estimates in most recent reports ›
BA beat the EPS estimate in 3 of its last 3 reports.
Key statistics
The headline figures for BA.
As of October 17, 2026, BA trades at $190.21, with a market value of $150.34B and a P/E ratio of 68.13.
What the numbers say
CleaRank Financial AI's reading of BA's valuation, growth and risks.
BA's trailing P/E of 68.13 is 100.4% above the Industrials median of 34.0, and the peer comparison on this page calls that a premium to peers. Measured against sales, the P/S of 1.59 sits 60.3% below the sector median P/S of 4.0. The company's market value stands at $150.3B.
In the latest year revenue grew 8.00%, 3.7 percentage points slower than the sector median of 11.7%. Margins stand at a net margin of 2.59% and an operating margin of 0.00%. Shareholders' capital earns 173.54%, above the sector median of 17.8%, measured as return on equity. Debt-to-equity of 7.91 rounds out the fundamentals.
In the most recent available report in our data, dated April 22, 2026, BA beat the estimate by 70.15%, reporting EPS of -$0.2 against the -$0.67 that analysts had forecast. The share price rose 1.24% in the following session.
Across its last 3 reports, BA beat the estimate every time, though the stock still fell in the first session after 1 of those 3 beats. Analysts' average EPS estimate for this fiscal year is -$1.11, which would be a decline of 193.2%, and $3.96 for next year.
Valuation leaves less margin for error: the P/E of 68.13 is 100.4% above the sector median, a premium to peers. Normal swings for BA run at about 2.00% a day. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 25.22% below its 52-week high of $254.35.
BA against the Industrials sector
How BA compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: BA trades at a significant premium to sector peers (+100%), suggesting market expectations for superior growth or market position.
Return vs XLI: Since May 6, 2025, BA has gained 2.3% against a gain of 25.7% for XLI.
Performance against XLI
BA and the Industrials sector fund over the same days.
Revenue and earnings
How much BA sells, and how much of it becomes profit.
Revenue growth: Revenue grew 34.5% in FY2025 to $89.5B, from $66.5B a year earlier.
Profit margin: The net margin was 2.5% in FY2025, up from -17.8% the year before.
Profitable: BA earned $2.2B in FY2025.
Earnings reality check
Did BA beat what analysts expected, and how did the stock react?
Earnings record: BA beat the analyst estimate in 3 of the last 3 quarters.
Market reaction: The stock fell in the first session after 1 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Apr 22, 2026after close | -$0.67 | -$0.20 | +70.15% | +1.24% | -3.10% |
| Jul 29, 2025after close | -$1.27 | -$1.24 | +2.36% | -0.11% | -0.54% |
| Apr 23, 2025after close | -$1.30 | -$0.49 | +62.31% | +2.26% | +6.31% |
Reports after April 22, 2026 are not yet in our data.
As of October 17, 2026, BA has beaten the analyst EPS estimate in 3 of its last 3 reported quarters and fell in the first trading session after 1 of those beats; its most recent report in our data, on April 22, 2026, came in 70.15% above the estimate and the stock moved +1.24% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 43.5, in neutral territory.RSI above 50 ›
An RSI of 43.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of BA
The score, the reasoning behind it, and what could move the price next.
The Boeing Company (BA) is in a downtrend: both moving averages sit above the price. At $190.21, the stock is 7.38% below its 50-day average of $205.37 and 13.34% below its 200-day average of $219.50. The price sits at 17% of its 52-week range and is 7.60% above the 52-week low of $176.77. The 50-day average is 6.44% below the 200-day, which backs up the weakness instead of cutting against it.
Every period on the chart shows a loss, with the price down 11.13% over the past three months, 14.85% over the past six months and 10.23% over the past year. On momentum, the 14-day RSI reads 43.5, in the neutral zone, with the MACD line negative.
Earnings beat ›
The April 22, 2026 report beat the EPS estimate by 70.15%, and the share price rose 1.24% in the first session after it.
Source: Earnings report, April 22, 2026Analyst upgrade ›
Argus Research upgraded it to Buy from Hold on August 11, 2026.
Source: Analyst action, Argus Research, August 11, 2026
New analyst coverage ›
Barclays started coverage at Overweight on October 9, 2026.
Source: Analyst action, Barclays, October 9, 2026
- The two closest levels matter most: the 20-day EMA at $192.32 sits above the price, and the 52-week low at $176.77 sits below it.
- The MACD line is negative and the 14-day RSI sits at 43.5, in the neutral zone. Readings above 70 or below 30 would signal stretched momentum.
- BA's share price rose 1.24% in the first session after the April 22, 2026 report, and the stock has beaten estimates in 3 of the last 3 reports.
BA remains in a downtrend while it sits below both its 50-day average of $205.37 and its 200-day average of $219.50. A move back above the 50-day would be the first sign of repair. Overhead, the 20-day EMA at $192.32 is the first hurdle a rally would meet.
The next level below the price is the 52-week low at $176.77. The 14-day RSI reads 43.5, which places it in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for BA, from its daily closes.
As of October 17, 2026, with BA at $190.21, its 14-day RSI is 43.5 (neutral territory), its 50-day simple moving average is $205.37 and its 200-day is $219.50.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, BA's 1-year correlation of daily returns is +0.53 with S&P 500 (SPY), +0.48 with Nasdaq 100 (QQQ), +0.27 with Bitcoin (BTC) and +0.22 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
24 of 28 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $270.00 is 41.9% above the price.More buy ratings than three months ago ›
24 of 28 rate it a buy now, against 21 of 28 three months ago.
BA Wall Street View
12-month price targets
The price, $190.21, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | TD Cowen | Maintains | Buy |
| Oct 9, 2026 | Barclays | Initiates | Overweight |
| Sep 21, 2026 | Jefferies | Maintains | Buy |
| Sep 18, 2026 | B of A Securities | Reiterates | Buy |
| Aug 11, 2026 | Argus Research | Upgrade | Buy |
| Aug 6, 2026 | Tigress Financial | Maintains | Buy |
As of October 17, 2026, 28 Wall Street analysts cover BA: 24 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $248.00 to $305.00, with a median of $270.00, 41.9% above the price of $190.21.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BA tends to move, against the market and on its own.
The long record
BA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.00% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 77.3%, from March 2019 to March 2020; the price is still 55.8% below that peak.Most 1-year holds ended higher ›
56% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $15,420, against $42,055 in the S&P 500 (SPY).
BA Drawdowns & Recovery
As of October 17, 2026, BA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -77.3% (March 2019 to March 2020); it is still 55.8% below that peak, and 56% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BA in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BA trailed the S&P 500 over this period: $15,420 against $42,055.
A $10,000 investment in BA in October 2016 would be worth about $15,420 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BA, and which have not.
Strongest month, November: an average of +9.03%, up in 7 of 10 years.
Weakest month, March: an average of -7.33%, up in 3 of 10 years.
This month, October: has averaged -2.26%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BA's strongest calendar month has been November (average +9.03%, up in 7 of 10 years) and its weakest March (average -7.33%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BA today could grow to about $16,315 by 2036 in the base case, with a 90th-percentile outcome near $89,502 and a 10th-percentile outcome around $2,974. Projections are statistical simulations, not guarantees.
BA Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $231 for BA by 2030 in the base case, from $190 today (1.2x over 4 years). The 10th-percentile path ends near $78.84. These are outcomes of a Monte Carlo simulation run on BA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $117 | $200 | $342 | |
| 2028 | $97.98 | $210 | $449 | |
| 2029 | $86.72 | $220 | $560 | |
| 2030 | $78.84 | $231 | $679 | |
| 2031 | $72.91 | $243 | $810 |
Method: a lognormal simulation of BA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $1.4M on the open market and sold $11.6M.
As of October 17, 2026, BA insiders reported 12 open-market sales worth $11.6M and 4 open-market purchases worth $1.4M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | David Christopher Raymond
Officer
|
Grant | 907 | - |
| May 20, 2026 | Bradley Douglas Tilden
Director
|
Buy | 1.4K | $299.3K |
| Mar 3, 2026 | Mortimer J. Buckley
Director
|
Buy | 2.2K | $500.0K |
| Feb 24, 2026 | Uma M Amuluru
Officer
|
Sell | 1.5K | $351.5K |
| Feb 17, 2026 | Ann M Schmidt
Officer
|
Sell | 6.3K | $1.5M |
| Feb 17, 2026 | Uma M Amuluru
Officer
|
Grant | 9.8K | - |
| Feb 17, 2026 | Michael J Cleary
Officer
|
Grant | 3.7K | - |
| Feb 17, 2026 | Dana S Deasy
Officer
|
Grant | 8.4K | - |
| Feb 17, 2026 | Brett C. Gerry
Officer
|
Grant | 13.0K | - |
| Feb 17, 2026 | Jesus Malave Jr.
Chief Financial Officer
|
Grant | 18.8K | - |
| Feb 17, 2026 | Howard E Mckenzie
Officer
|
Grant | 9.2K | - |
| Feb 17, 2026 | Brendan J. Nelson
Officer
|
Grant | 5.1K | - |
| Feb 17, 2026 | Robert Kelly Ortberg
Chief Executive Officer
|
Grant | 58.1K | - |
| Feb 17, 2026 | Stephen Kenneth Parker
Chief Executive Officer
|
Grant | 13.0K | - |
| Feb 17, 2026 | Stephanie F Pope
Officer
|
Grant | 28.9K | - |
| Feb 17, 2026 | David Christopher Raymond
Officer
|
Grant | 7.5K | - |
| Feb 17, 2026 | Ann M Schmidt
Officer
|
Grant | 4.3K | - |
| Feb 17, 2026 | Jeffrey S Shockey
Officer
|
Grant | 7.2K | - |
| Feb 5, 2026 | Howard E Mckenzie
Officer
|
Sell | 10.5K | $2.5M |
| Feb 4, 2026 | Uma M Amuluru
Officer
|
Sell | 2.7K | $644.6K |
| Nov 24, 2025 | Dana S Deasy
Officer
|
Buy | 554 | $99.1K |
| Nov 6, 2025 | Uma M Amuluru
Officer
|
Sell | 1.4K | $270.0K |
| Aug 19, 2025 | Mortimer J. Buckley
Director
|
Buy | 2.2K | $497.4K |
| Aug 15, 2025 | Jesus Malave Jr.
Chief Financial Officer
|
Grant | 21.4K | - |
| Aug 8, 2025 | David Christopher Raymond
Officer
|
Sell | 3.8K | $867.1K |
| May 15, 2025 | Brendan J. Nelson
President
|
Sell | 640 | $132.0K |
| May 13, 2025 | Jeffrey S Shockey
Officer
|
Sell | 3.2K | $650.2K |
| May 6, 2025 | Michael J Cleary
Officer
|
Sell | 3.0K | $558.0K |
| May 2, 2025 | David Christopher Raymond
Officer
|
Sell | 3.9K | $729.2K |
| May 1, 2025 | Stephanie F Pope
Officer
|
Sell | 16.8K | $3.1M |
| May 1, 2025 | Michael J Cleary
Officer
|
Sell | 2.0K | $368.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.